Table 1.
Participant characteristics (N = 141).
| n | % | |
|---|---|---|
| Clinical role | ||
| Clinical investigator | 122 | 86.5 |
| Research director, administrator, or manager | 15 | 10.6 |
| Research staff | 2 | 1.4 |
| Other clinical role | 2 | 1.4 |
| Practice type | ||
| Hospital or health system owned | 125 | 88.7 |
| Physician owned | 16 | 11.3 |
| Academic site (ie, has a fellowship program) | ||
| Yes | 111 | 78.7 |
| No | 30 | 21.3 |
| Experience as a PI (investigators only) | ||
| Study or site PI | 110 | 90.2 |
| Sub-investigator only | 10 | 8.2 |
| None | 2 | 1.6 |
| Trial participation, sponsors | ||
| Industry-sponsored trials | 137 | 97.2 |
| NCI-sponsored trials (ETCTN or NCTN) | 119 | 84.4 |
| Investigator-initiated trials | 117 | 83 |
| Trial participation, phases | ||
| Phase I trials | 116 | 82.3 |
| Phase II/III trials | 140 | 99.3 |
| Years of clinical trial experience | ||
| <10 years | 31 | 22.1 |
| 10-19 years | 52 | 37.1 |
| 20 or more years | 57 | 40.7 |
| Age | ||
| Under 45 | 54 | 38.6 |
| 45-59 | 51 | 36.4 |
| 60 or older | 35 | 25 |
| Gender | ||
| Female | 74 | 52.5 |
| Male | 65 | 46.1 |
| Nonbinary | 0 | 0 |
| Self-identify | 0 | 0 |
| Prefer not to answer | 2 | 1.4 |
| Race/ethnicity (select all that apply) | ||
| Black or African American | 1 | 0.7 |
| American Indian or Alaska Native | 0 | 0 |
| Native Hawaiian or other Pacific Islander | 0 | 0 |
| Asian | 27 | 19.1 |
| White | 98 | 69.5 |
| Latinx | 6 | 4.3 |
| Other | 3 | 2.1 |
| Prefer not to answer | 7 | 5 |
| Percentage of clinical trial patients that belong to a minority or underserved group | ||
| None (0%-5%) | 10 | 7.1 |
| Few (6%-25%) | 97 | 68.8 |
| Some (26%-50%) | 31 | 22 |
| Most (>50%) | 3 | 2.1 |
Abbreviations: PI: Principal Investigator.